Brief: Poxel Reports FY Revenue Of 0.7 Mln Euros

Poxel SA

15/02/2023 18:14

Feb 15 (Reuters) - Poxel SA  POXEL.PA :
    * REVENUE OF EUR 0.674 MILLION FOR FY2022
    * AS OF DECEMBER 31, 2022, CASH AND CASH EQUIVALENTS WERE
EUR 13.1
MILLION (USD 14 MILLION)
    * PHASE 2 NASH TRIAL (DESTINY-1) FOR PXL065 MET ITS PRIMARY
EFFICACY ENDPOINT FOR LIVER FAT CONTENT REDUCTION AT 36 WEEKS
FOR ALL DOSES
    * NET FINANCIAL DEBT (EXCLUDING IFRS 16 IMPACTS AND
DERIVATIVE
DEBTS) WAS EUR 29.5 MILLION  AT END OF Q4 2022
    * TWYMEEG® (IMEGLIMIN) RECENT GROWTH TRAJECTORY CONFIRMED
WITH A
90% INCREASE IN SALES IN JAPAN OVER PRIOR QUARTER, LEADING TO A
20% INCREASE OF FISCAL YEAR 2022 FORECAST
    * HAS OBTAINED A STANDSTILL OF ITS CURRENT DEBT OBLIGATIONS
FROM
IPF PARTNERS UNTIL MARCH 31, 2023
    * AFTER 6 YEARS AS CHIEF FINANCIAL OFFICER OF POXEL ANNE
RENEVOT
HAS RECENTLY LEFT POXEL TO PURSUE ANOTHER OPPORTUNITY
    * COMPANY PLANS TO LAUNCH SEARCH FOR A NEW CFO AND, IN
INTERIM,
CAN RELY ON ITS EXPERIENCED FINANCE TEAM

Source text for Eikon:  ID:nBw6vLBwda 
Further company coverage:  POXEL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))